# Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock

> **NCT03683329** · PHASE3 · COMPLETED · sponsor: **Institut Paoli-Calmettes** · enrollment: 398 (actual)

## Conditions studied

- Critical Care
- Cancer

## Interventions

- **OTHER:** Antibiotic de-escalation
- **OTHER:** Standard treatment

## Key facts

- **NCT ID:** NCT03683329
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-26
- **Primary completion:** 2024-07-26
- **Final completion:** 2024-07-26
- **Target enrollment:** 398 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683329, "Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03683329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*